Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

(2021) Adam Cuker et al.   Blood Advances

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Venous thromboembolism in COVID-19: A systematic review and meta-analysis

(2021) Anastasios Kollias et al.   VASCULAR MEDICINE

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis

(2021) Matthew Moll et al.   THROMBOSIS RESEARCH

Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19

(2020) Alex C. Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

(2020) Grigoris T. Gerotziafas et al.   THROMBOSIS AND HAEMOSTASIS

Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019

(2020) David Jiménez et al.   CHEST

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?

(2020) Anastasios Kollias et al.   THROMBOSIS RESEARCH